VENUS is the only clinical trial network in the U.S. focused solely on venous thrombosis and counts more than 128 investigators in 38+ states. As a member of the International Network of VENous Thromboembolism (INVENT), VENUS fosters international collaborative research.
60,000-100,000 Americans die of DVT/PE each year
1/3-1/2 of people with DVT will experience long-term complications
Half of blood clots occur during or soon after a hospital stay or surgery
1/3 of people with DVT/PE will have a recurrence within 10 years
Source: Centers for Disease Control and Prevention
Venous thromboEmbolism Network U.S. (VENUS)
Get Involved | About Us | Research and Discoveries | Donate | Contact Us
© 2022 Versiti. All rights reserved.